Press Archive - Page 2 of 34 - Stand Up To Cancer


Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.


June 12, 2019

Drs. Carpten and Pettigrew Are Named to Stand Up To Cancer Scientific Advisory Committee

Stand Up To Cancer (SU2C) with its Scientific Partner, the American Association for Cancer Research (AACR), announced two new members of the SU2C Scientific Advisory Committee (SAC): John D. Carpten, PhD, director of the Institute of Translational Genomics at the Keck School of Medicine of the University of Southern California (USC), and Roderic I. Pettigrew, PhD, MD, chief executive officer of Engineering Health (EnHealth) and executive dean for Engineering Medicine (EnMed), at Texas A&M University.
Read More
June 11, 2019

Stand Up To Cancer Hails FDA Approval of ALPELISIB + FULVESTRANT Combination For Patients With A PIK3CA Mutation in HR+/HER2- Advanced Breast Cancer

Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval of alpelisib in combination with fulvestrant, the first and only new therapy for a difficult to treat form of advanced or metastatic breast cancer in both post-menopausal women and in men.
Read More
May 31, 2019

Stand Up To Cancer – Funded Research To Be Presented At ASCO Annual Meeting May 31 – June 4 in Chicago

Researchers whose work has been supported by Stand Up To Cancer, including Uri Tabori, MD, Hospital for Sick Children, Toronto, and Nabil M. Ahmed, MD, Baylor College of Medicine, will discuss their work in advancing immunotherapy for pediatric brain tumors at the Annual Meeting 2019 of the American Society of Clinical Oncology May 31-June 4 at McCormick Place in Chicago.
Read More
May 2, 2019

“Innovation in Collaboration” among Research Teams Rewarded by Grants from Stand Up To Cancer

Stand Up To Cancer (SU2C) announced five new awards today drawing on the strengths of existing research activities to explore cross-cutting questions that have the potential of opening new paths to improved cancer treatment, according to the American Association for Cancer Research, SU2C’s Scientific Partner.
Read More
April 18, 2019

Stand Up To Cancer, Mastercard & Marvel Studios’ Avengers: Endgame Unite To Help Take Down One Of The Biggest Villains Of All: Cancer

Stand Up To Cancer (SU2C), Mastercard and Marvel Studios’ Avengers: Endgame announced today that they are teaming up to take down one of the biggest villains of all, cancer, with an impactful new Public Service Announcement scheduled to launch in April.
Read More
April 17, 2019

Key Protein A Possible New Target in the Treatment of Pancreatic Cancer Pancreatic Cancer Collective Supports Important Study Published in Nature

Research funded by the Pancreatic Cancer Collective, a partnership between Lustgarten Foundation and Stand Up To Cancer and guided by Dr. Tony Hunter at the Salk Institute was published today in Nature and has found that the interaction between pancreatic stellate cells (PSC’s) and pancreatic cancer cells could be “exploitable” due to the presence of a key protein and lead to the development of new targeted strategies for pancreatic cancer therapy.
Read More
March 31, 2019

Stand Up To Cancer Supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting

Stand Up To Cancer (SU2C) is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia and other blood cancers to solid tumors such as osteosarcoma and mesothelioma. If ultimately successful, the research could pave the way for a dramatic expansion of a therapy that has revolutionized treatment of blood malignancies but thus far, has had little impact on the solid tumors that make up most cancer cases.
Read More
March 30, 2019

The Pancreatic Cancer Collective Funds Two New Research Teams Using Artificial Intelligence to Identify High-Risk Pancreatic Cancer Populations

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), today announced two, million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations.
Read More
March 28, 2019

Stand Up To Cancer Hails Election of SU2C Team Leader as President-elect of American Association for Cancer Research

Stand Up To Cancer is hailing the election of active SU2C researcher and world-famous scientist, Antoni Ribas, MD, PhD, as the 2019-2020 president-elect of the American Association for Cancer Research, SU2C’s Scientific Partner.
Read More
March 27, 2019

Stand Up To Cancer Funded Research to be Presented March 30 – April 3 at AACR Annual Meeting

 Nobel Laureate James P. Allison, PhD, and other acclaimed researchers will be presenting their research funded by Stand Up To Cancer (SU2C) at the American Association for Cancer Research Annual (AACR) Meeting 2019 from March 29th to April 3rd, the Georgia World Congress Center (GWCC) in Atlanta.
Read More


Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.